[1]Ando,Kumiko;Kawamura,Yoko;Akai,Yukiko;Kunitomo,Jun-Ichi;Yokomizo,Takehiko;Yamashita,Masayuki;Ohta,Shunsaku;Ohishi,Takahiro;Ohishi,Yoshitaka[OrganicandBiomolecularChemistry,2008,vol.6,#2,p.296-307]
[2]CurrentPatentAssignee:SYNERGENICSLCC-WO2012/119046,2012,A2Locationinpatent:Page/Pagecolumn181
[3]Yoo,Sung-Eun;Lee,Seung-Heui;Kim,Soo-Kyung;Lee,Sung-Hou[BioorganicandMedicinalChemistry,1997,vol.5,#2,p.445-459]
[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/103546,2011,A1Locationinpatent:Page/Pagecolumn61
[5]Liu,Zhiyuan;Wu,Wenliang;Yang,Jiangyu;Li,Meichao;Hu,Xinquan;Hu,Baoxiang;Jin,Liqun;Sun,Nan;Shen,Zhenlu[Tetrahedron,2022,vol.119]
Title: Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
Journal: Journal of medicinal chemistry 20061116